Clinical Trial Update: A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye [Phase 4]

View source ↗

Summary

Phase 4 trial update for OPTIVE FUSION with VISMED Multi in dry eye conditions shows completed study with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Keratoconjunctivitis Sicca

Drugs mentioned

• OPTIVE FUSION
• VISMED Multi

Snippet

Sponsor: Allergan | Conditions: Dry Eye Syndromes, Keratoconjunctivitis Sicca | Phase 4 | Status: COMPLETED | Results posted: 2016-02-19